Frequency News and Research

RSS

Detrol LA significantly reduces symptoms of overactive bladder

Pfizer today announced results of a comprehensive six-year review of efficacy and safety data for Detrol LA (tolterodine tartrate extended release capsules) indicating that Detrol LA significantly reduces symptoms of overactive bladder (OAB) with a low occurrence of side effects, and should be considered first-line therapy.

13 Dec 2004

Notebook computers can have a negative effect on male fertility

US fertility experts are warning teenage boys and young men to consider limiting the time that they use notebook computers positioned on their laps, as long-term use may affect their fertility.

13 Dec 2004

Discovery of key immune system molecules that helps determine how effectively a person resists HIV infection

A team of researchers based partly in South Africa has identified a key set of immune system molecules that helps determine how effectively a person resists infection with human immunodeficiency virus (HIV).

8 Dec 2004

Cardiovascular experts issue blueprint for safer X-Ray imaging

Millions of invasive cardiovascular procedures that involve the use of potentially hazardous X-rays are done in the United States each year.

8 Dec 2004

Physically fit men visit their doctors less frequently

Physically fit men had fewer overnight hospital stays and visited their doctors less frequently, according to the results of a long-term study published this month in Medicine & Science in Sports & Exercise, the official scientific journal of the American College of Sports Medicine (ACSM).

7 Dec 2004

New advances in sickle cell disease

Excruciating pain episodes, recurrent pneumonias, strokes, severe infections, chronic hemolytic anemia, and secondary pulmonary hypertension are common complications of sickle cell disease, a life-threatening inherited defect in blood that causes normally disc-shaped red blood cells to take on a sickle shape.

6 Dec 2004

Sexologist unveils a formula for a better sex life

After centuries of human sexual relations, a leading expert today unveiled the 'Sexual Quotient' (SQ), a formula to help couples assess and improve their sex lives.

6 Dec 2004

As mobile phone use rises, possibility of unseen biological impact is quietly troubling

Cell biologists are of two minds about the possible biological effects of mobile phone radiation. In the mid-1990s, studies describing possible pathological effects on tissues bombarded with low-level radio frequencies (RF) were first featured in the popular press and then discredited by scientists.

4 Dec 2004

Phase 3 results of Genasense plus Dexamethasone in patients with advanced multiple myeloma

Genta Incorporated announced that results from the Company's randomized Phase 3 clinical trial of Genasense(R) (oblimersen sodium) Injection in patients with relapsed or refractory multiple myeloma were presented today at the annual meeting of the American Society of Hematology (ASH) in San Diego, CA.

4 Dec 2004

Study focused on patients with chemotherapy-related anemia

Findings from an interim analysis of a new study comparing the hemoglobin response rates of Epoetin alfa and darbepoetin alfa in the treatment of chemotherapy-related anemia were published in the November 15, 2004 issue of the Medical Journal 'Blood' as part of the American Society of Hematology 46th Annual Meeting and Exposition.

4 Dec 2004

Having a job reduces likelihood of drug use

It's said that "idle hands are the devil's workshop." A pair of University of Houston professors studying employment and drug use now provide support for that proverb.

30 Nov 2004

Iris Murdoch's last novel reveals signs of the first stages of Alzheimer’s disease

The last novel written by author Iris Murdoch before she died reveals signs of the first stages of Alzheimer’s disease, according to a study published in the latest online issue of Brain.

29 Nov 2004

FDA approval of Tysabri, for the treatment of multiple sclerosis

Biogen and Elan Corporation have announced that the U.S. Food and Drug Administration (FDA) has approved Tysabri (natalizumab), as treatment for relapsing forms of multiple sclerosis (MS) to reduce the frequency of clinical relapses.

24 Nov 2004

FDA approves Vesicare (solifenacin succinate) for the treatment of overactive bladder

Vesicare (solifenacin succinate) has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of overactive bladder (OAB) with symptoms of urgency, frequency, and urge incontinence.

23 Nov 2004

Urinary incontinence and abdominal pain are key symptoms of ovarian cancer

Results from an Olmsted Medical Center and Mayo Clinic study analyzing symptoms recorded in the medical records of ovarian cancer patients suggest ovarian cancer, long considered asymptomatic until late-stage cancer develops, does in fact have early symptoms, including urinary incontinence and abdominal pain.

18 Nov 2004

Sit down rounds improve outcomes for kidney dialysis patients

"Sit-down" medical rounds, during which a health care team meets to review a patient's medical record and discuss short- and long-term needs, are associated with better outcomes for kidney dialysis patients, a Johns Hopkins-directed study has found.

17 Nov 2004

FDA commits to use of radio frequency identification (RFID) technology

The U.S. Food and Drug Administration (FDA) is stepping up its efforts to improve the safety and security of the nation's drug supply through the use of radio frequency identification (RFID) technology.

16 Nov 2004

Sildenafil tablets will soon have small radio frequency tags

In an effort to combat drug counterfeiting and protect patients, Pfizer has announced a new initiative to use radio frequency identification (RFID) tags that will enable wholesalers and pharmacies to authenticate all Viagra sold in the United States.

16 Nov 2004

The brain's dopamine system is key to alcoholism

Among the many genes that may contribute to an individual's susceptibility to alcoholism, those in the dopamine system are of special interest because addictive substances can activate this system.

14 Nov 2004

The risk of developing metabolic syndrome increases the more a person drinks

The risk of developing metabolic syndrome increases the more a person drinks – and beginning a heavy drinking pattern early in life seems to add extra risk, according to a first-of-its-kind study presented at the American Heart Association’s Scientific Sessions 2004.

11 Nov 2004